| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | I-SMAD binding | 1.88e-14 | 17 | 24 | 6 | GO:0070411 | |
| GeneOntologyMolecularFunction | SMAD binding | 6.76e-10 | 86 | 24 | 6 | GO:0046332 | |
| GeneOntologyMolecularFunction | DEAD/H-box RNA helicase binding | 1.28e-07 | 9 | 24 | 3 | GO:0017151 | |
| GeneOntologyMolecularFunction | co-SMAD binding | 3.33e-07 | 12 | 24 | 3 | GO:0070410 | |
| GeneOntologyMolecularFunction | R-SMAD binding | 3.90e-06 | 26 | 24 | 3 | GO:0070412 | |
| GeneOntologyMolecularFunction | ubiquitin protein ligase binding | 4.34e-05 | 337 | 24 | 5 | GO:0031625 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase binding | 5.78e-05 | 358 | 24 | 5 | GO:0044389 | |
| GeneOntologyMolecularFunction | CCR6 chemokine receptor binding | 1.07e-04 | 13 | 24 | 2 | GO:0031731 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 4.61e-04 | 127 | 24 | 3 | GO:0008094 | |
| GeneOntologyMolecularFunction | cytokine receptor binding | 5.59e-04 | 324 | 24 | 4 | GO:0005126 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 6.13e-04 | 140 | 24 | 3 | GO:0001221 | |
| GeneOntologyMolecularFunction | transforming growth factor beta receptor binding | 6.30e-04 | 31 | 24 | 2 | GO:0005160 | |
| GeneOntologyMolecularFunction | helicase activity | 8.71e-04 | 158 | 24 | 3 | GO:0004386 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 8.99e-04 | 37 | 24 | 2 | GO:0140658 | |
| GeneOntologyMolecularFunction | neuropeptide binding | 8.99e-04 | 37 | 24 | 2 | GO:0042923 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 1.84e-03 | 53 | 24 | 2 | GO:0008188 | |
| GeneOntologyMolecularFunction | chemoattractant activity | 1.91e-03 | 54 | 24 | 2 | GO:0042056 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 1.91e-03 | 54 | 24 | 2 | GO:0001223 | |
| GeneOntologyMolecularFunction | CCR chemokine receptor binding | 2.05e-03 | 56 | 24 | 2 | GO:0048020 | |
| GeneOntologyMolecularFunction | transcription corepressor binding | 2.27e-03 | 59 | 24 | 2 | GO:0001222 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 2.94e-03 | 1244 | 24 | 6 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 3.27e-03 | 1271 | 24 | 6 | GO:0000987 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 3.69e-03 | 262 | 24 | 3 | GO:0140097 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 4.16e-03 | 560 | 24 | 4 | GO:0001228 | |
| GeneOntologyMolecularFunction | collagen binding | 4.23e-03 | 81 | 24 | 2 | GO:0005518 | |
| GeneOntologyMolecularFunction | chemokine receptor binding | 4.23e-03 | 81 | 24 | 2 | GO:0042379 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 4.32e-03 | 566 | 24 | 4 | GO:0001216 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 5.51e-03 | 1412 | 24 | 6 | GO:0000981 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 6.46e-03 | 1459 | 24 | 6 | GO:0000977 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor binding | 7.41e-03 | 337 | 24 | 3 | GO:0001664 | |
| GeneOntologyMolecularFunction | chromatin binding | 1.10e-02 | 739 | 24 | 4 | GO:0003682 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 1.10e-02 | 133 | 24 | 2 | GO:0008528 | |
| GeneOntologyMolecularFunction | transcription factor binding | 1.17e-02 | 753 | 24 | 4 | GO:0008134 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 1.22e-02 | 140 | 24 | 2 | GO:0001653 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 1.32e-02 | 417 | 24 | 3 | GO:0061629 | |
| GeneOntologyBiologicalProcess | embryonic pattern specification | 7.88e-10 | 91 | 24 | 6 | GO:0009880 | |
| GeneOntologyBiologicalProcess | ureteric bud development | 2.11e-09 | 107 | 24 | 6 | GO:0001657 | |
| GeneOntologyBiologicalProcess | SMAD protein signal transduction | 2.50e-09 | 110 | 24 | 6 | GO:0060395 | |
| GeneOntologyBiologicalProcess | mesonephric tubule development | 2.50e-09 | 110 | 24 | 6 | GO:0072164 | |
| GeneOntologyBiologicalProcess | mesonephric epithelium development | 2.50e-09 | 110 | 24 | 6 | GO:0072163 | |
| GeneOntologyBiologicalProcess | mesonephros development | 2.94e-09 | 113 | 24 | 6 | GO:0001823 | |
| GeneOntologyBiologicalProcess | kidney epithelium development | 2.56e-08 | 162 | 24 | 6 | GO:0072073 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 5.98e-07 | 276 | 24 | 6 | GO:0007179 | |
| GeneOntologyBiologicalProcess | primary miRNA processing | 1.56e-06 | 20 | 24 | 3 | GO:0031053 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 1.88e-06 | 336 | 24 | 6 | GO:0071560 | |
| GeneOntologyBiologicalProcess | connective tissue development | 2.12e-06 | 343 | 24 | 6 | GO:0061448 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 2.12e-06 | 343 | 24 | 6 | GO:0071559 | |
| GeneOntologyBiologicalProcess | BMP signaling pathway | 2.77e-06 | 197 | 24 | 5 | GO:0030509 | |
| GeneOntologyBiologicalProcess | kidney development | 3.38e-06 | 372 | 24 | 6 | GO:0001822 | |
| GeneOntologyBiologicalProcess | renal system development | 4.18e-06 | 386 | 24 | 6 | GO:0072001 | |
| GeneOntologyBiologicalProcess | response to BMP | 4.25e-06 | 215 | 24 | 5 | GO:0071772 | |
| GeneOntologyBiologicalProcess | cellular response to BMP stimulus | 4.25e-06 | 215 | 24 | 5 | GO:0071773 | |
| GeneOntologyBiologicalProcess | skeletal system development | 4.50e-06 | 615 | 24 | 7 | GO:0001501 | |
| GeneOntologyBiologicalProcess | adrenal gland development | 4.96e-06 | 29 | 24 | 3 | GO:0030325 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 9.44e-06 | 445 | 24 | 6 | GO:0141091 | |
| GeneOntologyBiologicalProcess | response to chloroquine | 1.29e-05 | 5 | 24 | 2 | GO:1902349 | |
| GeneOntologyBiologicalProcess | Mullerian duct regression | 1.29e-05 | 5 | 24 | 2 | GO:0001880 | |
| GeneOntologyBiologicalProcess | cardiac conduction system development | 1.33e-05 | 40 | 24 | 3 | GO:0003161 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 1.49e-05 | 482 | 24 | 6 | GO:0007178 | |
| GeneOntologyBiologicalProcess | cardiac muscle hypertrophy in response to stress | 1.54e-05 | 42 | 24 | 3 | GO:0014898 | |
| GeneOntologyBiologicalProcess | muscle hypertrophy in response to stress | 1.54e-05 | 42 | 24 | 3 | GO:0003299 | |
| GeneOntologyBiologicalProcess | cardiac muscle adaptation | 1.66e-05 | 43 | 24 | 3 | GO:0014887 | |
| GeneOntologyBiologicalProcess | osteoblast fate commitment | 1.94e-05 | 6 | 24 | 2 | GO:0002051 | |
| GeneOntologyBiologicalProcess | miRNA processing | 2.31e-05 | 48 | 24 | 3 | GO:0035196 | |
| GeneOntologyBiologicalProcess | pattern specification process | 2.43e-05 | 526 | 24 | 6 | GO:0007389 | |
| GeneOntologyBiologicalProcess | mesoderm development | 3.05e-05 | 157 | 24 | 4 | GO:0007498 | |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta2 production | 3.62e-05 | 8 | 24 | 2 | GO:0032909 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta2 production | 3.62e-05 | 8 | 24 | 2 | GO:0032906 | |
| GeneOntologyBiologicalProcess | striated muscle tissue development | 4.40e-05 | 349 | 24 | 5 | GO:0014706 | |
| GeneOntologyBiologicalProcess | activin receptor signaling pathway | 4.53e-05 | 60 | 24 | 3 | GO:0032924 | |
| GeneOntologyBiologicalProcess | positive regulation of miRNA transcription | 4.77e-05 | 61 | 24 | 3 | GO:1902895 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial to mesenchymal transition | 5.25e-05 | 63 | 24 | 3 | GO:0010718 | |
| GeneOntologyBiologicalProcess | mesenchyme morphogenesis | 5.77e-05 | 65 | 24 | 3 | GO:0072132 | |
| GeneOntologyBiologicalProcess | embryonic foregut morphogenesis | 7.09e-05 | 11 | 24 | 2 | GO:0048617 | |
| GeneOntologyBiologicalProcess | positive regulation of miRNA metabolic process | 8.16e-05 | 73 | 24 | 3 | GO:2000630 | |
| GeneOntologyBiologicalProcess | striated muscle adaptation | 8.16e-05 | 73 | 24 | 3 | GO:0014888 | |
| GeneOntologyBiologicalProcess | regulatory ncRNA processing | 8.50e-05 | 74 | 24 | 3 | GO:0070918 | |
| GeneOntologyBiologicalProcess | foregut morphogenesis | 8.50e-05 | 12 | 24 | 2 | GO:0007440 | |
| GeneOntologyBiologicalProcess | positive chemotaxis | 8.85e-05 | 75 | 24 | 3 | GO:0050918 | |
| GeneOntologyBiologicalProcess | gastrulation | 9.81e-05 | 212 | 24 | 4 | GO:0007369 | |
| GeneOntologyBiologicalProcess | paraxial mesoderm morphogenesis | 1.00e-04 | 13 | 24 | 2 | GO:0048340 | |
| GeneOntologyBiologicalProcess | mesoderm formation | 1.15e-04 | 82 | 24 | 3 | GO:0001707 | |
| GeneOntologyBiologicalProcess | regulation of miRNA transcription | 1.20e-04 | 83 | 24 | 3 | GO:1902893 | |
| GeneOntologyBiologicalProcess | miRNA transcription | 1.24e-04 | 84 | 24 | 3 | GO:0061614 | |
| GeneOntologyBiologicalProcess | mesoderm morphogenesis | 1.33e-04 | 86 | 24 | 3 | GO:0048332 | |
| GeneOntologyBiologicalProcess | positive regulation of extracellular matrix assembly | 1.35e-04 | 15 | 24 | 2 | GO:1901203 | |
| GeneOntologyBiologicalProcess | endoderm development | 1.42e-04 | 88 | 24 | 3 | GO:0007492 | |
| GeneOntologyBiologicalProcess | cartilage development | 1.66e-04 | 243 | 24 | 4 | GO:0051216 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | 1.74e-04 | 750 | 24 | 6 | GO:0048729 | |
| GeneOntologyBiologicalProcess | heart development | 1.83e-04 | 757 | 24 | 6 | GO:0007507 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | 2.15e-04 | 1125 | 24 | 7 | GO:0035239 | |
| GeneOntologyBiologicalProcess | regulation of miRNA metabolic process | 2.27e-04 | 103 | 24 | 3 | GO:2000628 | |
| GeneOntologyBiologicalProcess | bone development | 2.28e-04 | 264 | 24 | 4 | GO:0060348 | |
| GeneOntologyBiologicalProcess | anatomical structure regression | 2.43e-04 | 20 | 24 | 2 | GO:0060033 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | 3.42e-04 | 850 | 24 | 6 | GO:0071363 | |
| GeneOntologyBiologicalProcess | miRNA metabolic process | 3.47e-04 | 119 | 24 | 3 | GO:0010586 | |
| GeneOntologyBiologicalProcess | mesenchymal cell differentiation | 3.52e-04 | 296 | 24 | 4 | GO:0048762 | |
| GeneOntologyBiologicalProcess | paraxial mesoderm development | 3.53e-04 | 24 | 24 | 2 | GO:0048339 | |
| GeneOntologyBiologicalProcess | muscle system process | 3.60e-04 | 547 | 24 | 5 | GO:0003012 | |
| GeneOntologyBiologicalProcess | osteoblast differentiation | 3.80e-04 | 302 | 24 | 4 | GO:0001649 | |
| GeneOntologyBiologicalProcess | growth | 3.81e-04 | 1235 | 24 | 7 | GO:0040007 | |
| GeneOntologyBiologicalProcess | segmentation | 3.82e-04 | 123 | 24 | 3 | GO:0035282 | |
| GeneOntologyBiologicalProcess | formation of primary germ layer | 3.91e-04 | 124 | 24 | 3 | GO:0001704 | |
| GeneOntologyBiologicalProcess | muscle tissue development | 3.95e-04 | 558 | 24 | 5 | GO:0060537 | |
| GeneOntologyBiologicalProcess | gland development | 3.95e-04 | 558 | 24 | 5 | GO:0048732 | |
| GeneOntologyBiologicalProcess | nodal signaling pathway | 4.15e-04 | 26 | 24 | 2 | GO:0038092 | |
| GeneOntologyBiologicalProcess | response to growth factor | 4.20e-04 | 883 | 24 | 6 | GO:0070848 | |
| GeneOntologyBiologicalProcess | secondary palate development | 4.47e-04 | 27 | 24 | 2 | GO:0062009 | |
| GeneOntologyBiologicalProcess | regulation of epithelial to mesenchymal transition | 4.49e-04 | 130 | 24 | 3 | GO:0010717 | |
| GeneOntologyBiologicalProcess | pericardium development | 4.81e-04 | 28 | 24 | 2 | GO:0060039 | |
| GeneOntologyBiologicalProcess | signal transduction involved in regulation of gene expression | 4.81e-04 | 28 | 24 | 2 | GO:0023019 | |
| GeneOntologyBiologicalProcess | developmental growth | 4.96e-04 | 911 | 24 | 6 | GO:0048589 | |
| GeneOntologyBiologicalProcess | cardiac muscle tissue development | 5.13e-04 | 327 | 24 | 4 | GO:0048738 | |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix assembly | 5.17e-04 | 29 | 24 | 2 | GO:1901201 | |
| GeneOntologyBiologicalProcess | cell fate commitment | 5.81e-04 | 338 | 24 | 4 | GO:0045165 | |
| GeneOntologyBiologicalProcess | cardiac muscle hypertrophy | 5.82e-04 | 142 | 24 | 3 | GO:0003300 | |
| GeneOntologyBiologicalProcess | chemosensory behavior | 5.91e-04 | 31 | 24 | 2 | GO:0007635 | |
| GeneOntologyBiologicalProcess | striated muscle hypertrophy | 6.31e-04 | 146 | 24 | 3 | GO:0014897 | |
| GeneOntologyBiologicalProcess | muscle hypertrophy | 6.56e-04 | 148 | 24 | 3 | GO:0014896 | |
| GeneOntologyBiologicalProcess | positive regulation of extracellular matrix organization | 7.12e-04 | 34 | 24 | 2 | GO:1903055 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 7.77e-04 | 1390 | 24 | 7 | GO:0045944 | |
| GeneOntologyBiologicalProcess | positive regulation of cartilage development | 7.98e-04 | 36 | 24 | 2 | GO:0061036 | |
| GeneOntologyBiologicalProcess | tube development | 8.18e-04 | 1402 | 24 | 7 | GO:0035295 | |
| GeneOntologyBiologicalProcess | mesenchyme development | 8.31e-04 | 372 | 24 | 4 | GO:0060485 | |
| GeneOntologyBiologicalProcess | endocrine system development | 8.38e-04 | 161 | 24 | 3 | GO:0035270 | |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta production | 8.43e-04 | 37 | 24 | 2 | GO:0071634 | |
| GeneOntologyBiologicalProcess | muscle adaptation | 8.84e-04 | 164 | 24 | 3 | GO:0043500 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta production | 9.85e-04 | 40 | 24 | 2 | GO:0071604 | |
| GeneOntologyBiologicalProcess | response to organic cyclic compound | 1.04e-03 | 1048 | 24 | 6 | GO:0014070 | |
| GeneOntologyBiologicalProcess | regulation of binding | 1.05e-03 | 396 | 24 | 4 | GO:0051098 | |
| GeneOntologyBiologicalProcess | epithelium development | 1.08e-03 | 1469 | 24 | 7 | GO:0060429 | |
| GeneOntologyCellularComponent | heteromeric SMAD protein complex | 3.25e-17 | 8 | 24 | 6 | GO:0071144 | |
| GeneOntologyCellularComponent | SMAD protein complex | 2.43e-16 | 10 | 24 | 6 | GO:0071141 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 5.08e-07 | 272 | 24 | 6 | GO:0090575 | |
| GeneOntologyCellularComponent | homomeric SMAD protein complex | 1.26e-06 | 2 | 24 | 2 | GO:0071142 | |
| GeneOntologyCellularComponent | activin responsive factor complex | 3.79e-06 | 3 | 24 | 2 | GO:0032444 | |
| GeneOntologyCellularComponent | transcription regulator complex | 4.55e-05 | 596 | 24 | 6 | GO:0005667 | |
| GeneOntologyCellularComponent | chromatin | 1.63e-04 | 1480 | 24 | 8 | GO:0000785 | |
| GeneOntologyCellularComponent | neuronal cell body membrane | 1.11e-03 | 43 | 24 | 2 | GO:0032809 | |
| GeneOntologyCellularComponent | cell body membrane | 1.32e-03 | 47 | 24 | 2 | GO:0044298 | |
| GeneOntologyCellularComponent | nuclear inner membrane | 2.08e-03 | 59 | 24 | 2 | GO:0005637 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 3.89e-03 | 1377 | 24 | 6 | GO:0140513 | |
| GeneOntologyCellularComponent | neuromuscular junction | 7.27e-03 | 112 | 24 | 2 | GO:0031594 | |
| HumanPheno | Mucoid extracellular matrix accumulation | 3.64e-06 | 19 | 9 | 3 | HP:0200146 | |
| HumanPheno | Medial degeneration | 3.64e-06 | 19 | 9 | 3 | HP:0032079 | |
| HumanPheno | Cystic medial necrosis | 3.64e-06 | 19 | 9 | 3 | HP:0012180 | |
| HumanPheno | Descending thoracic aorta aneurysm | 3.64e-06 | 19 | 9 | 3 | HP:0004959 | |
| HumanPheno | Paroxysmal dyspnea | 4.28e-06 | 20 | 9 | 3 | HP:0012763 | |
| HumanPheno | Descending aortic dissection | 4.99e-06 | 21 | 9 | 3 | HP:0012499 | |
| HumanPheno | Dural ectasia | 7.58e-06 | 24 | 9 | 3 | HP:0100775 | |
| HumanPheno | Carotid artery dilatation | 7.58e-06 | 24 | 9 | 3 | HP:0012163 | |
| HumanPheno | Chronic fatigue | 8.61e-06 | 25 | 9 | 3 | HP:0012432 | |
| HumanPheno | Abnormal spinal meningeal morphology | 8.61e-06 | 25 | 9 | 3 | HP:0010303 | |
| HumanPheno | Ascending aortic dissection | 9.72e-06 | 26 | 9 | 3 | HP:0004933 | |
| HumanPheno | Abnormal ascending aorta morphology | 1.09e-05 | 27 | 9 | 3 | HP:0031784 | |
| HumanPheno | Abnormal subarachnoid space morphology | 1.39e-05 | 96 | 9 | 4 | HP:0012703 | |
| HumanPheno | Abnormality of blood volume homeostasis | 1.84e-05 | 32 | 9 | 3 | HP:0011104 | |
| HumanPheno | Hypovolemia | 1.84e-05 | 32 | 9 | 3 | HP:0011106 | |
| HumanPheno | Peripheral arterial stenosis | 2.03e-05 | 33 | 9 | 3 | HP:0004950 | |
| HumanPheno | Ischemic stroke | 3.12e-05 | 38 | 9 | 3 | HP:0002140 | |
| HumanPheno | Cerebral infarct | 3.38e-05 | 39 | 9 | 3 | HP:0025722 | |
| HumanPheno | Subarachnoid hemorrhage | 3.38e-05 | 39 | 9 | 3 | HP:0002138 | |
| HumanPheno | Aortic dissection | 3.65e-05 | 40 | 9 | 3 | HP:0002647 | |
| HumanPheno | Intervertebral disk degeneration | 4.15e-05 | 6 | 9 | 2 | HP:0008419 | |
| HumanPheno | Osteochondritis dissecans | 5.80e-05 | 7 | 9 | 2 | HP:0010886 | |
| HumanPheno | Dilatation of the cerebral artery | 7.61e-05 | 51 | 9 | 3 | HP:0004944 | |
| HumanPheno | Aortic tortuosity | 7.73e-05 | 8 | 9 | 2 | HP:0006687 | |
| HumanPheno | High, narrow palate | 9.46e-05 | 156 | 9 | 4 | HP:0002705 | |
| HumanPheno | Uterine rupture | 9.93e-05 | 9 | 9 | 2 | HP:0100718 | |
| HumanPheno | Bifid uvula | 1.23e-04 | 167 | 9 | 4 | HP:0000193 | |
| HumanPheno | Transient ischemic attack | 1.30e-04 | 61 | 9 | 3 | HP:0002326 | |
| HumanPheno | Abnormal spinal cord morphology | 1.64e-04 | 357 | 9 | 5 | HP:0002143 | |
| HumanPheno | Arterial dissection | 1.81e-04 | 12 | 9 | 2 | HP:0005294 | |
| HumanPheno | Osteochondrosis | 1.81e-04 | 12 | 9 | 2 | HP:0040188 | |
| HumanPheno | Aortic root aneurysm | 1.97e-04 | 70 | 9 | 3 | HP:0002616 | |
| HumanPheno | Cutis marmorata | 2.14e-04 | 72 | 9 | 3 | HP:0000965 | |
| HumanPheno | Abnormal uvula morphology | 2.35e-04 | 197 | 9 | 4 | HP:0000172 | |
| HumanPheno | Narrow palate | 2.59e-04 | 202 | 9 | 4 | HP:0000189 | |
| HumanPheno | Pneumothorax | 2.61e-04 | 77 | 9 | 3 | HP:0002107 | |
| HumanPheno | Knee osteoarthritis | 2.88e-04 | 15 | 9 | 2 | HP:0005086 | |
| HumanPheno | Spontaneous pneumothorax | 3.29e-04 | 16 | 9 | 2 | HP:0002108 | |
| HumanPheno | Dilatation of the ascending aorta | 3.38e-04 | 84 | 9 | 3 | HP:0005111 | |
| HumanPheno | Hemoptysis | 3.88e-04 | 88 | 9 | 3 | HP:0002105 | |
| HumanPheno | Hip osteoarthritis | 4.18e-04 | 18 | 9 | 2 | HP:0008843 | |
| HumanPheno | Abnormal carotid artery morphology | 4.43e-04 | 92 | 9 | 3 | HP:0005344 | |
| HumanPheno | Cleft soft palate | 4.86e-04 | 238 | 9 | 4 | HP:0000185 | |
| HumanPheno | Malar flattening | 5.02e-04 | 240 | 9 | 4 | HP:0000272 | |
| HumanPheno | Cleft secondary palate | 5.02e-04 | 240 | 9 | 4 | HP:0410004 | |
| HumanPheno | Abnormal malar bone morphology | 5.78e-04 | 249 | 9 | 4 | HP:0012369 | |
| HumanPheno | Abnormal zygomatic arch morphology | 5.87e-04 | 250 | 9 | 4 | HP:0005557 | |
| HumanPheno | Abnormal zygomatic bone morphology | 5.87e-04 | 250 | 9 | 4 | HP:0010668 | |
| HumanPheno | Cerebral hemorrhage | 6.17e-04 | 103 | 9 | 3 | HP:0001342 | |
| HumanPheno | Aortic regurgitation | 6.17e-04 | 103 | 9 | 3 | HP:0001659 | |
| HumanPheno | Dermal atrophy | 6.90e-04 | 107 | 9 | 3 | HP:0004334 | |
| HumanPheno | Bicuspid aortic valve | 9.42e-04 | 119 | 9 | 3 | HP:0001647 | |
| HumanPheno | Dermal translucency | 9.52e-04 | 27 | 9 | 2 | HP:0010648 | |
| HumanPheno | Abnormal aortic valve cusp morphology | 9.89e-04 | 121 | 9 | 3 | HP:0031567 | |
| HumanPheno | Thoracic aortic aneurysm | 9.89e-04 | 121 | 9 | 3 | HP:0012727 | |
| HumanPheno | Abnormal soft palate morphology | 1.02e-03 | 289 | 9 | 4 | HP:0100736 | |
| HumanPheno | Cerebral ischemia | 1.04e-03 | 123 | 9 | 3 | HP:0002637 | |
| HumanPheno | Tissue ischemia | 1.04e-03 | 123 | 9 | 3 | HP:0033401 | |
| HumanPheno | Abdominal aortic aneurysm | 1.09e-03 | 125 | 9 | 3 | HP:0005112 | |
| HumanPheno | Arterial tortuosity | 1.26e-03 | 31 | 9 | 2 | HP:0005116 | |
| HumanPheno | Hypoplastic iliac wing | 1.26e-03 | 31 | 9 | 2 | HP:0002866 | |
| HumanPheno | Arachnodactyly | 1.30e-03 | 133 | 9 | 3 | HP:0001166 | |
| HumanPheno | Cardiomegaly | 1.30e-03 | 133 | 9 | 3 | HP:0001640 | |
| HumanPheno | Varicose veins | 1.34e-03 | 32 | 9 | 2 | HP:0002619 | |
| HumanPheno | Abnormal sputum | 1.39e-03 | 136 | 9 | 3 | HP:0032016 | |
| HumanPheno | Chest pain | 1.42e-03 | 137 | 9 | 3 | HP:0100749 | |
| HumanPheno | Pulmonic stenosis | 1.45e-03 | 138 | 9 | 3 | HP:0001642 | |
| HumanPheno | Abnormal meningeal morphology | 1.57e-03 | 324 | 9 | 4 | HP:0010651 | |
| HumanPheno | Vascular tortuosity | 1.60e-03 | 35 | 9 | 2 | HP:0004948 | |
| HumanPheno | Hypoplastic facial bones | 1.70e-03 | 331 | 9 | 4 | HP:0002692 | |
| HumanPheno | Aplasia/Hypoplasia of facial bones | 1.72e-03 | 332 | 9 | 4 | HP:0034261 | |
| HumanPheno | Exertional dyspnea | 1.74e-03 | 147 | 9 | 3 | HP:0002875 | |
| HumanPheno | Striae distensae | 1.89e-03 | 38 | 9 | 2 | HP:0001065 | |
| HumanPheno | Migraine | 1.99e-03 | 154 | 9 | 3 | HP:0002076 | |
| HumanPheno | Abnormal left ventricular function | 2.03e-03 | 155 | 9 | 3 | HP:0005162 | |
| HumanPheno | Abnormal vascular physiology | 2.05e-03 | 348 | 9 | 4 | HP:0030163 | |
| HumanPheno | Intracranial hemorrhage | 2.07e-03 | 156 | 9 | 3 | HP:0002170 | |
| HumanPheno | Venous insufficiency | 2.09e-03 | 40 | 9 | 2 | HP:0005293 | |
| HumanPheno | Slender finger | 2.18e-03 | 159 | 9 | 3 | HP:0001238 | |
| HumanPheno | Disproportionate tall stature | 2.20e-03 | 41 | 9 | 2 | HP:0001519 | |
| HumanPheno | Abnormal pulmonary valve physiology | 2.34e-03 | 163 | 9 | 3 | HP:0031654 | |
| HumanPheno | Abnormal venous morphology | 2.37e-03 | 362 | 9 | 4 | HP:0002624 | |
| HumanPheno | Juvenile aseptic necrosis | 2.41e-03 | 43 | 9 | 2 | HP:0100323 | |
| HumanPheno | Coronary artery atherosclerosis | 2.47e-03 | 166 | 9 | 3 | HP:0001677 | |
| HumanPheno | Soft skin | 2.53e-03 | 44 | 9 | 2 | HP:0000977 | |
| HumanPheno | Aortic dilatation | 2.56e-03 | 168 | 9 | 3 | HP:0001724 | |
| HumanPheno | Long toe | 2.56e-03 | 168 | 9 | 3 | HP:0010511 | |
| HumanPheno | Aortic aneurysm | 2.56e-03 | 168 | 9 | 3 | HP:0004942 | |
| HumanPheno | Abnormal cerebral artery morphology | 2.69e-03 | 171 | 9 | 3 | HP:0009145 | |
| HumanPheno | Abnormal intervertebral disk morphology | 2.76e-03 | 46 | 9 | 2 | HP:0005108 | |
| HumanPheno | Abnormal cardiac ventricular function | 2.78e-03 | 173 | 9 | 3 | HP:0030872 | |
| HumanPheno | Aplasia/hypoplasia affecting bones of the axial skeleton | 2.87e-03 | 1008 | 9 | 6 | HP:0009122 | |
| HumanPheno | Bruising susceptibility | 3.02e-03 | 178 | 9 | 3 | HP:0000978 | |
| HumanPheno | Abnormal arterial physiology | 3.16e-03 | 181 | 9 | 3 | HP:0025323 | |
| HumanPheno | Abnormal coronary artery morphology | 3.16e-03 | 181 | 9 | 3 | HP:0006704 | |
| HumanPheno | Pregnancy history | 3.21e-03 | 182 | 9 | 3 | HP:0002686 | |
| HumanPheno | Past medical history | 3.26e-03 | 183 | 9 | 3 | HP:0032443 | |
| MousePheno | rostral body truncation | 3.28e-06 | 21 | 20 | 3 | MP:0012157 | |
| MousePheno | abnormal rostral-caudal axis patterning | 3.27e-05 | 132 | 20 | 4 | MP:0005221 | |
| MousePheno | abnormal visceral endoderm morphology | 1.08e-04 | 66 | 20 | 3 | MP:0011186 | |
| MousePheno | abnormal proximal-distal axis patterning | 1.50e-04 | 13 | 20 | 2 | MP:0001705 | |
| MousePheno | abnormal mesoderm development | 1.52e-04 | 74 | 20 | 3 | MP:0001680 | |
| MousePheno | abnormal craniofacial development | 2.70e-04 | 425 | 20 | 5 | MP:0003935 | |
| MousePheno | abnormal chorioallantoic fusion | 2.72e-04 | 90 | 20 | 3 | MP:0002824 | |
| MousePheno | abnormal embryonic epiblast morphology | 3.09e-04 | 94 | 20 | 3 | MP:0003886 | |
| MousePheno | abnormal egg cylinder morphology | 3.09e-04 | 94 | 20 | 3 | MP:0003085 | |
| MousePheno | absent egg cylinders | 3.64e-04 | 20 | 20 | 2 | MP:0001694 | |
| MousePheno | abnormal bilaminar embryonic disk morphology | 3.93e-04 | 102 | 20 | 3 | MP:0012103 | |
| MousePheno | abnormal ventral body wall morphology | 4.02e-04 | 21 | 20 | 2 | MP:0003384 | |
| MousePheno | abnormal allantois morphology | 5.17e-04 | 112 | 20 | 3 | MP:0001726 | |
| MousePheno | decreased primordial germ cell number | 7.71e-04 | 29 | 20 | 2 | MP:0008392 | |
| MousePheno | abnormal foregut morphology | 8.26e-04 | 30 | 20 | 2 | MP:0000474 | |
| MousePheno | abnormal extraembryonic ectoderm morphology | 8.82e-04 | 31 | 20 | 2 | MP:0010736 | |
| MousePheno | abnormal primordial germ cell morphology | 1.00e-03 | 33 | 20 | 2 | MP:0008391 | |
| MousePheno | abnormal embryonic-extraembryonic boundary morphology | 1.06e-03 | 34 | 20 | 2 | MP:0003890 | |
| MousePheno | abnormal germ layer development | 1.07e-03 | 144 | 20 | 3 | MP:0001674 | |
| MousePheno | abnormal polar trophectoderm morphology | 1.40e-03 | 39 | 20 | 2 | MP:0012056 | |
| MousePheno | abnormal ectoplacental cone morphology | 1.40e-03 | 39 | 20 | 2 | MP:0005032 | |
| MousePheno | abnormal placenta development | 1.45e-03 | 160 | 20 | 3 | MP:0001712 | |
| Domain | Dwarfin | 6.39e-17 | 8 | 24 | 6 | IPR013790 | |
| Domain | - | 6.39e-17 | 8 | 24 | 6 | 3.90.520.10 | |
| Domain | MAD_homology_MH1 | 6.39e-17 | 8 | 24 | 6 | IPR013019 | |
| Domain | MH2 | 6.39e-17 | 8 | 24 | 6 | PS51076 | |
| Domain | MH1 | 6.39e-17 | 8 | 24 | 6 | PS51075 | |
| Domain | MH2 | 6.39e-17 | 8 | 24 | 6 | PF03166 | |
| Domain | SMAD_dom_Dwarfin-type | 6.39e-17 | 8 | 24 | 6 | IPR001132 | |
| Domain | DWB | 6.39e-17 | 8 | 24 | 6 | SM00524 | |
| Domain | MH1 | 2.10e-15 | 12 | 24 | 6 | PF03165 | |
| Domain | MAD_homology1_Dwarfin-type | 2.10e-15 | 12 | 24 | 6 | IPR003619 | |
| Domain | DWA | 2.10e-15 | 12 | 24 | 6 | SM00523 | |
| Domain | SMAD_dom-like | 1.81e-14 | 16 | 24 | 6 | IPR017855 | |
| Domain | - | 1.81e-14 | 16 | 24 | 6 | 2.60.200.10 | |
| Domain | SMAD_FHA_domain | 4.48e-11 | 52 | 24 | 6 | IPR008984 | |
| Domain | MRGPCRFAMILY | 8.64e-05 | 11 | 24 | 2 | IPR026234 | |
| Domain | Defensin_beta-typ | 1.04e-04 | 12 | 24 | 2 | IPR001855 | |
| Domain | Defensin_beta | 1.04e-04 | 12 | 24 | 2 | PF00711 | |
| Domain | Helicase_C | 3.39e-04 | 107 | 24 | 3 | PF00271 | |
| Domain | HELICc | 3.39e-04 | 107 | 24 | 3 | SM00490 | |
| Domain | Helicase_C | 3.48e-04 | 108 | 24 | 3 | IPR001650 | |
| Domain | HELICASE_CTER | 3.58e-04 | 109 | 24 | 3 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 3.58e-04 | 109 | 24 | 3 | PS51192 | |
| Domain | SNF2_N | 7.67e-04 | 32 | 24 | 2 | PF00176 | |
| Domain | SNF2_N | 7.67e-04 | 32 | 24 | 2 | IPR000330 | |
| Domain | DEXDc | 8.57e-03 | 109 | 24 | 2 | SM00487 | |
| Domain | Helicase_ATP-bd | 8.72e-03 | 110 | 24 | 2 | IPR014001 | |
| Pathway | WP_TGFBETA_SIGNALING_PATHWAY | 7.85e-11 | 53 | 20 | 6 | MM15880 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING | 9.90e-11 | 55 | 20 | 6 | M39351 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP15_SIGNALING_PATHWAY | 1.03e-10 | 7 | 20 | 4 | M47845 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 1.53e-10 | 59 | 20 | 6 | M39886 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MYOSTATIN_SIGNALING_PATHWAY | 2.05e-10 | 8 | 20 | 4 | M47847 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AMH_SIGNALING_PATHWAY | 3.69e-10 | 9 | 20 | 4 | M47844 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP9_10_SIGNALING_PATHWAY | 3.69e-10 | 9 | 20 | 4 | M47822 | |
| Pathway | PID_ALK2_PATHWAY | 9.66e-10 | 11 | 20 | 4 | M203 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP_HAMP_SIGNALING_PATHWAY | 9.66e-10 | 11 | 20 | 4 | M47848 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 1.42e-09 | 37 | 20 | 5 | M39506 | |
| Pathway | KEGG_TGF_BETA_SIGNALING_PATHWAY | 1.56e-09 | 86 | 20 | 6 | M2642 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 1.07e-08 | 118 | 20 | 6 | MM15588 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BMP_SIGNALING_PATHWAY | 1.41e-08 | 20 | 20 | 4 | M47843 | |
| Pathway | PID_ALK1_PATHWAY | 4.32e-08 | 26 | 20 | 4 | M185 | |
| Pathway | REACTOME_SIGNALING_BY_NODAL | 4.87e-08 | 6 | 20 | 3 | MM14517 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 6.86e-08 | 161 | 20 | 6 | M27871 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES | 8.52e-08 | 7 | 20 | 3 | MM15661 | |
| Pathway | REACTOME_LOSS_OF_FUNCTION_OF_SMAD2_3_IN_CANCER | 8.52e-08 | 7 | 20 | 3 | M29623 | |
| Pathway | REACTOME_SIGNALING_BY_BMP | 9.04e-08 | 31 | 20 | 4 | M1662 | |
| Pathway | REACTOME_SIGNALING_BY_BMP | 9.04e-08 | 31 | 20 | 4 | MM14789 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGF_BETA_SIGNALING_PATHWAY | 1.36e-07 | 8 | 20 | 3 | M47415 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NODAL_SIGNALING_PATHWAY | 1.36e-07 | 8 | 20 | 3 | M47849 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACTIVIN_SIGNALING_PATHWAY | 1.36e-07 | 8 | 20 | 3 | M47846 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX_IN_CANCER | 1.36e-07 | 8 | 20 | 3 | M27246 | |
| Pathway | PID_BMP_PATHWAY | 3.19e-07 | 42 | 20 | 4 | M181 | |
| Pathway | WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING | 3.40e-07 | 108 | 20 | 5 | M48078 | |
| Pathway | WP_TGFB_SMAD_SIGNALING | 5.33e-07 | 12 | 20 | 3 | M48091 | |
| Pathway | WP_ID_SIGNALING_PATHWAY | 6.51e-07 | 50 | 20 | 4 | MM15817 | |
| Pathway | WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION | 6.92e-07 | 13 | 20 | 3 | M39378 | |
| Pathway | REACTOME_SIGNALING_BY_ACTIVIN | 1.10e-06 | 15 | 20 | 3 | MM14593 | |
| Pathway | PID_SMAD2_3PATHWAY | 1.35e-06 | 16 | 20 | 3 | M228 | |
| Pathway | REACTOME_GERM_LAYER_FORMATION_AT_GASTRULATION | 1.64e-06 | 17 | 20 | 3 | M45017 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING | 1.64e-06 | 17 | 20 | 3 | M39686 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 1.64e-06 | 17 | 20 | 3 | MM1509 | |
| Pathway | REACTOME_FORMATION_OF_DEFINITIVE_ENDODERM | 1.64e-06 | 17 | 20 | 3 | M48030 | |
| Pathway | REACTOME_SIGNALING_BY_ACTIVIN | 1.64e-06 | 17 | 20 | 3 | M26965 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES | 1.64e-06 | 17 | 20 | 3 | M27946 | |
| Pathway | WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION | 2.33e-06 | 19 | 20 | 3 | M39370 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 2.33e-06 | 19 | 20 | 3 | M18933 | |
| Pathway | WP_BMP_SIGNALING_PATHWAY_IN_EYELID_DEVELOPMENT | 2.74e-06 | 20 | 20 | 3 | MM15907 | |
| Pathway | WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT | 2.74e-06 | 20 | 20 | 3 | M39624 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 3.70e-06 | 22 | 20 | 3 | MM15656 | |
| Pathway | WP_PROGERIAASSOCIATED_LIPODYSTROPHY | 3.70e-06 | 22 | 20 | 3 | M42534 | |
| Pathway | REACTOME_SIGNALING_BY_NODAL | 4.25e-06 | 23 | 20 | 3 | M511 | |
| Pathway | WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM | 4.35e-06 | 80 | 20 | 4 | M45523 | |
| Pathway | BIOCARTA_CTCF_PATHWAY | 4.85e-06 | 24 | 20 | 3 | M11420 | |
| Pathway | REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY | 4.85e-06 | 24 | 20 | 3 | MM14877 | |
| Pathway | BIOCARTA_CTCF_PATHWAY | 4.85e-06 | 24 | 20 | 3 | MM1373 | |
| Pathway | WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE | 5.51e-06 | 25 | 20 | 3 | M39665 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 5.51e-06 | 25 | 20 | 3 | M39713 | |
| Pathway | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | 6.22e-06 | 26 | 20 | 3 | MM14878 | |
| Pathway | WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS | 8.72e-06 | 29 | 20 | 3 | M39516 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_OXIDATIVE_STRESS_METABOLIC_AND_NEURONAL_GENES | 9.68e-06 | 30 | 20 | 3 | M27941 | |
| Pathway | REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY | 1.07e-05 | 31 | 20 | 3 | M669 | |
| Pathway | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | 1.69e-05 | 36 | 20 | 3 | M633 | |
| Pathway | BIOCARTA_ALK_PATHWAY | 1.84e-05 | 37 | 20 | 3 | M17400 | |
| Pathway | WP_ESC_PLURIPOTENCY_PATHWAYS | 1.90e-05 | 116 | 20 | 4 | MM15863 | |
| Pathway | REACTOME_RUNX3_REGULATES_BCL2L11_BIM_TRANSCRIPTION | 1.91e-05 | 5 | 20 | 2 | M27825 | |
| Pathway | WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS | 1.97e-05 | 117 | 20 | 4 | M39530 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 2.00e-05 | 38 | 20 | 3 | MM14874 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 2.04e-05 | 118 | 20 | 4 | M39852 | |
| Pathway | WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA | 2.33e-05 | 40 | 20 | 3 | M48337 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 2.52e-05 | 41 | 20 | 3 | MM14876 | |
| Pathway | REACTOME_RUNX3_REGULATES_CDKN1A_TRANSCRIPTION | 2.86e-05 | 6 | 20 | 2 | MM15534 | |
| Pathway | WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY | 3.57e-05 | 46 | 20 | 3 | M39828 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 3.81e-05 | 47 | 20 | 3 | M646 | |
| Pathway | REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT | 4.00e-05 | 7 | 20 | 2 | MM15533 | |
| Pathway | REACTOME_RUNX3_REGULATES_CDKN1A_TRANSCRIPTION | 4.00e-05 | 7 | 20 | 2 | M27807 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 4.87e-05 | 51 | 20 | 3 | M665 | |
| Pathway | WP_MESODERMAL_COMMITMENT_PATHWAY | 5.65e-05 | 153 | 20 | 4 | M39546 | |
| Pathway | PID_TGFBR_PATHWAY | 5.78e-05 | 54 | 20 | 3 | M286 | |
| Pathway | WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER | 5.78e-05 | 54 | 20 | 3 | M42568 | |
| Pathway | WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME | 8.34e-05 | 61 | 20 | 3 | M48077 | |
| Pathway | KEGG_COLORECTAL_CANCER | 8.76e-05 | 62 | 20 | 3 | M14631 | |
| Pathway | PID_MYC_REPRESS_PATHWAY | 9.19e-05 | 63 | 20 | 3 | M254 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 1.06e-04 | 66 | 20 | 3 | MM15925 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 1.06e-04 | 66 | 20 | 3 | M27938 | |
| Pathway | WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION | 1.25e-04 | 12 | 20 | 2 | M39519 | |
| Pathway | WP_MIR127_IN_MESENDODERM_DIFFERENTIATION | 1.25e-04 | 12 | 20 | 2 | MM15910 | |
| Pathway | KEGG_PANCREATIC_CANCER | 1.26e-04 | 70 | 20 | 3 | M9726 | |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | 1.33e-04 | 191 | 20 | 4 | MM15289 | |
| Pathway | WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER | 1.43e-04 | 73 | 20 | 3 | M39758 | |
| Pathway | KEGG_ADHERENS_JUNCTION | 1.43e-04 | 73 | 20 | 3 | M638 | |
| Pathway | WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY | 1.48e-04 | 74 | 20 | 3 | M48080 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 1.67e-04 | 77 | 20 | 3 | MM14670 | |
| Pathway | REACTOME_FORMATION_OF_AXIAL_MESODERM | 1.72e-04 | 14 | 20 | 2 | M46441 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 2.01e-04 | 82 | 20 | 3 | MM15922 | |
| Pathway | PID_SMAD2_3NUCLEAR_PATHWAY | 2.01e-04 | 82 | 20 | 3 | M2 | |
| Pathway | REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING | 2.27e-04 | 16 | 20 | 2 | MM14873 | |
| Pathway | REACTOME_SARS_COV_1_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS | 2.27e-04 | 16 | 20 | 2 | M46428 | |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | 2.34e-04 | 221 | 20 | 4 | M27578 | |
| Pathway | WP_PANCREATIC_ADENOCARCINOMA_PATHWAY | 2.57e-04 | 89 | 20 | 3 | M39732 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 3.01e-04 | 94 | 20 | 3 | M1041 | |
| Pathway | BIOCARTA_TOB1_PATHWAY | 3.22e-04 | 19 | 20 | 2 | M18215 | |
| Pathway | WP_HYPOXIADEPENDENT_PROLIFERATION_OF_MYOBLASTS | 3.22e-04 | 19 | 20 | 2 | MM15811 | |
| Pathway | BIOCARTA_TOB1_PATHWAY | 3.22e-04 | 19 | 20 | 2 | MM1490 | |
| Pathway | REACTOME_BETA_DEFENSINS | 3.58e-04 | 20 | 20 | 2 | MM14567 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 4.34e-04 | 22 | 20 | 2 | MM1443 | |
| Pathway | WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES | 4.34e-04 | 22 | 20 | 2 | M39773 | |
| Pathway | REACTOME_DEUBIQUITINATION | 4.47e-04 | 262 | 20 | 4 | MM15286 | |
| Pubmed | 5.48e-20 | 6 | 24 | 6 | 11850197 | ||
| Pubmed | Negative regulation of BMP/Smad signaling by Tob in osteoblasts. | 3.83e-19 | 7 | 24 | 6 | 11163184 | |
| Pubmed | A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension. | 1.53e-18 | 8 | 24 | 6 | 19211612 | |
| Pubmed | 1.53e-18 | 8 | 24 | 6 | 10647776 | ||
| Pubmed | 1.53e-18 | 8 | 24 | 6 | 10708949 | ||
| Pubmed | 4.60e-18 | 9 | 24 | 6 | 9759503 | ||
| Pubmed | 4.60e-18 | 9 | 24 | 6 | 10708948 | ||
| Pubmed | TGF-β signaling inhibits canonical BMP signaling pathway during palate development. | 1.15e-17 | 10 | 24 | 6 | 29247325 | |
| Pubmed | 1.15e-17 | 10 | 24 | 6 | 23620745 | ||
| Pubmed | 2.53e-17 | 11 | 24 | 6 | 24008158 | ||
| Pubmed | 5.05e-17 | 12 | 24 | 6 | 17460146 | ||
| Pubmed | 5.05e-17 | 12 | 24 | 6 | 14656760 | ||
| Pubmed | Endoglin is required for myogenic differentiation potential of neural crest stem cells. | 9.37e-17 | 13 | 24 | 6 | 17628518 | |
| Pubmed | 1.00e-16 | 5 | 24 | 5 | 25141865 | ||
| Pubmed | 1.64e-16 | 14 | 24 | 6 | 25274628 | ||
| Pubmed | Loss of Smad4 in the scleraxis cell lineage results in postnatal joint contracture. | 1.64e-16 | 14 | 24 | 6 | 33248111 | |
| Pubmed | Smad7 is required for the development and function of the heart. | 6.01e-16 | 6 | 24 | 5 | 18952608 | |
| Pubmed | 6.01e-16 | 6 | 24 | 5 | 11169847 | ||
| Pubmed | 6.01e-16 | 6 | 24 | 5 | 10400677 | ||
| Pubmed | 2.10e-15 | 7 | 24 | 5 | 15009097 | ||
| Pubmed | 2.10e-15 | 7 | 24 | 5 | 10376010 | ||
| Pubmed | 2.10e-15 | 7 | 24 | 5 | 12370310 | ||
| Pubmed | Interaction with Smad4 is indispensable for suppression of BMP signaling by c-Ski. | 2.10e-15 | 7 | 24 | 5 | 14699069 | |
| Pubmed | Myocardial smad4 is essential for cardiogenesis in mouse embryos. | 4.06e-15 | 22 | 24 | 6 | 17585069 | |
| Pubmed | 5.61e-15 | 8 | 24 | 5 | 10531362 | ||
| Pubmed | 5.61e-15 | 8 | 24 | 5 | 23804438 | ||
| Pubmed | 1.26e-14 | 9 | 24 | 5 | 19018011 | ||
| Pubmed | GATA4 is essential for bone mineralization via ERα and TGFβ/BMP pathways. | 1.26e-14 | 9 | 24 | 5 | 24932701 | |
| Pubmed | Dullard/Ctdnep1 regulates endochondral ossification via suppression of TGF-β signaling. | 1.26e-14 | 9 | 24 | 5 | 25155999 | |
| Pubmed | 1.26e-14 | 9 | 24 | 5 | 30134160 | ||
| Pubmed | 1.26e-14 | 9 | 24 | 5 | 26555259 | ||
| Pubmed | 1.26e-14 | 9 | 24 | 5 | 24816837 | ||
| Pubmed | Protein Arginine Methyltransferase PRMT1 Is Essential for Palatogenesis. | 2.52e-14 | 10 | 24 | 5 | 29986157 | |
| Pubmed | Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. | 2.52e-14 | 10 | 24 | 5 | 9436979 | |
| Pubmed | Disruption of transforming growth factor-beta signaling in ELF beta-spectrin-deficient mice. | 2.52e-14 | 10 | 24 | 5 | 12543979 | |
| Pubmed | 3.99e-14 | 31 | 24 | 6 | 36445780 | ||
| Pubmed | Smad2 and Smad3 Regulate Chondrocyte Proliferation and Differentiation in the Growth Plate. | 4.62e-14 | 11 | 24 | 5 | 27741240 | |
| Pubmed | 7.92e-14 | 12 | 24 | 5 | 21538804 | ||
| Pubmed | Connexin 40, a target of transcription factor Tbx5, patterns wrist, digits, and sternum. | 7.92e-14 | 12 | 24 | 5 | 15923624 | |
| Pubmed | Essential functions of Alk3 during AV cushion morphogenesis in mouse embryonic hearts. | 1.29e-13 | 13 | 24 | 5 | 16959237 | |
| Pubmed | Enhanced BMP signaling results in supernumerary tooth formation in USAG-1 deficient mouse. | 1.29e-13 | 13 | 24 | 5 | 18329379 | |
| Pubmed | 1.74e-13 | 4 | 24 | 4 | 9111321 | ||
| Pubmed | 1.74e-13 | 4 | 24 | 4 | 19247629 | ||
| Pubmed | Signal transduction of bone morphogenetic protein receptors. | 1.74e-13 | 4 | 24 | 4 | 14687659 | |
| Pubmed | Structural basis for the cooperative DNA recognition by Smad4 MH1 dimers. | 1.74e-13 | 4 | 24 | 4 | 21724602 | |
| Pubmed | Functions of mammalian Smad genes as revealed by targeted gene disruption in mice. | 1.74e-13 | 4 | 24 | 4 | 10708952 | |
| Pubmed | Matrix GLA protein, an inhibitory morphogen in pulmonary vascular development. | 2.00e-13 | 14 | 24 | 5 | 17670744 | |
| Pubmed | 2.00e-13 | 14 | 24 | 5 | 38951500 | ||
| Pubmed | 2.00e-13 | 14 | 24 | 5 | 16790475 | ||
| Pubmed | 2.00e-13 | 14 | 24 | 5 | 16435884 | ||
| Pubmed | 3.00e-13 | 15 | 24 | 5 | 23011393 | ||
| Pubmed | 3.00e-13 | 15 | 24 | 5 | 23946498 | ||
| Pubmed | 4.36e-13 | 16 | 24 | 5 | 19733164 | ||
| Pubmed | 4.36e-13 | 16 | 24 | 5 | 22438570 | ||
| Pubmed | 4.36e-13 | 16 | 24 | 5 | 21939397 | ||
| Pubmed | Dynamic signaling network for the specification of embryonic pancreas and liver progenitors. | 4.36e-13 | 16 | 24 | 5 | 19556507 | |
| Pubmed | SMAD4 is essential for generating subtypes of neurons during cerebellar development. | 6.17e-13 | 17 | 24 | 5 | 22370000 | |
| Pubmed | Smad4 controls proliferation of interstitial cells in the neonatal kidney. | 6.17e-13 | 17 | 24 | 5 | 34878095 | |
| Pubmed | 6.60e-13 | 48 | 24 | 6 | 27703004 | ||
| Pubmed | 8.54e-13 | 18 | 24 | 5 | 27720610 | ||
| Pubmed | 8.54e-13 | 18 | 24 | 5 | 23546880 | ||
| Pubmed | Ski represses bone morphogenic protein signaling in Xenopus and mammalian cells. | 8.71e-13 | 5 | 24 | 4 | 11121043 | |
| Pubmed | 8.71e-13 | 5 | 24 | 4 | 18566469 | ||
| Pubmed | Carboxy-terminally truncated Gli3 proteins associate with Smads. | 8.71e-13 | 5 | 24 | 4 | 9843199 | |
| Pubmed | 8.71e-13 | 5 | 24 | 4 | 15647271 | ||
| Pubmed | Smad8B, a Smad8 splice variant lacking the SSXS site that inhibits Smad8-mediated signalling. | 8.71e-13 | 5 | 24 | 4 | 10583507 | |
| Pubmed | 8.71e-13 | 5 | 24 | 4 | 11387330 | ||
| Pubmed | 8.71e-13 | 5 | 24 | 4 | 12808092 | ||
| Pubmed | 8.71e-13 | 5 | 24 | 4 | 19819941 | ||
| Pubmed | USP15 is a deubiquitylating enzyme for receptor-activated SMADs. | 8.71e-13 | 5 | 24 | 4 | 21947082 | |
| Pubmed | The MH1 domain of Smad3 interacts with Pax6 and represses autoregulation of the Pax6 P1 promoter. | 8.71e-13 | 5 | 24 | 4 | 17251190 | |
| Pubmed | 8.71e-13 | 5 | 24 | 4 | 8673135 | ||
| Pubmed | 1.16e-12 | 19 | 24 | 5 | 23776616 | ||
| Pubmed | Fgf9 signaling regulates small intestinal elongation and mesenchymal development. | 1.54e-12 | 20 | 24 | 5 | 18653563 | |
| Pubmed | RAB23 coordinates early osteogenesis by repressing FGF10-pERK1/2 and GLI1. | 1.54e-12 | 20 | 24 | 5 | 32662771 | |
| Pubmed | 2.61e-12 | 6 | 24 | 4 | 10890911 | ||
| Pubmed | 2.61e-12 | 6 | 24 | 4 | 9256479 | ||
| Pubmed | 2.61e-12 | 6 | 24 | 4 | 21518886 | ||
| Pubmed | Repression of Smad transcriptional activity by PIASy, an inhibitor of activated STAT. | 2.61e-12 | 6 | 24 | 4 | 12904571 | |
| Pubmed | 2.61e-12 | 6 | 24 | 4 | 19135894 | ||
| Pubmed | Control of early fate decisions in human ES cells by distinct states of TGFbeta pathway activity. | 2.61e-12 | 6 | 24 | 4 | 18393632 | |
| Pubmed | Smad proteins function as co-modulators for MEF2 transcriptional regulatory proteins. | 2.61e-12 | 6 | 24 | 4 | 11160896 | |
| Pubmed | Receptor-associated Mad homologues synergize as effectors of the TGF-beta response. | 2.61e-12 | 6 | 24 | 4 | 8774881 | |
| Pubmed | Genetic variation in the TGF-β signaling pathway and colon and rectal cancer risk. | 2.61e-12 | 6 | 24 | 4 | 21068203 | |
| Pubmed | PRDM16/MEL1: a novel Smad binding protein expressed in murine embryonic orofacial tissue. | 2.61e-12 | 6 | 24 | 4 | 17467076 | |
| Pubmed | Repression of bone morphogenetic protein and activin-inducible transcription by Evi-1. | 2.61e-12 | 6 | 24 | 4 | 15849193 | |
| Pubmed | SMAD expression in the testis: an insight into BMP regulation of spermatogenesis. | 2.61e-12 | 6 | 24 | 4 | 18069690 | |
| Pubmed | 3.35e-12 | 23 | 24 | 5 | 30842446 | ||
| Pubmed | 3.35e-12 | 23 | 24 | 5 | 21937600 | ||
| Pubmed | 3.35e-12 | 23 | 24 | 5 | 29981310 | ||
| Pubmed | 4.22e-12 | 24 | 24 | 5 | 34129836 | ||
| Pubmed | 4.22e-12 | 24 | 24 | 5 | 16943282 | ||
| Pubmed | Neural crest cell-autonomous roles of fibronectin in cardiovascular development. | 4.22e-12 | 24 | 24 | 5 | 26552887 | |
| Pubmed | 5.28e-12 | 25 | 24 | 5 | 20019329 | ||
| Pubmed | 6.09e-12 | 7 | 24 | 4 | 15376321 | ||
| Pubmed | CHIP mediates degradation of Smad proteins and potentially regulates Smad-induced transcription. | 6.09e-12 | 7 | 24 | 4 | 14701756 | |
| Pubmed | Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. | 6.09e-12 | 7 | 24 | 4 | 14580334 | |
| Pubmed | 6.09e-12 | 7 | 24 | 4 | 12874272 | ||
| Pubmed | A component of the ARC/Mediator complex required for TGF beta/Nodal signalling. | 6.09e-12 | 7 | 24 | 4 | 12167862 | |
| Pubmed | 6.09e-12 | 7 | 24 | 4 | 23933588 | ||
| Interaction | TOB1 interactions | 7.46e-12 | 44 | 23 | 6 | int:TOB1 | |
| Interaction | SMAD5 interactions | 1.48e-11 | 101 | 23 | 7 | int:SMAD5 | |
| Interaction | CSH2 interactions | 1.74e-09 | 15 | 23 | 4 | int:CSH2 | |
| Interaction | CSH1 interactions | 3.90e-09 | 18 | 23 | 4 | int:CSH1 | |
| Interaction | RASL12 interactions | 6.17e-09 | 20 | 23 | 4 | int:RASL12 | |
| Interaction | HMGA2 interactions | 9.24e-09 | 140 | 23 | 6 | int:HMGA2 | |
| Interaction | COL5A1 interactions | 9.60e-09 | 65 | 23 | 5 | int:COL5A1 | |
| Interaction | ZNF8 interactions | 1.40e-08 | 70 | 23 | 5 | int:ZNF8 | |
| Interaction | SMAD9 interactions | 1.57e-08 | 153 | 23 | 6 | int:SMAD9 | |
| Interaction | RASD2 interactions | 1.60e-08 | 25 | 23 | 4 | int:RASD2 | |
| Interaction | ZEB2 interactions | 6.58e-08 | 95 | 23 | 5 | int:ZEB2 | |
| Interaction | RAB38 interactions | 9.27e-08 | 38 | 23 | 4 | int:RAB38 | |
| Interaction | COL3A1 interactions | 1.03e-07 | 39 | 23 | 4 | int:COL3A1 | |
| Interaction | CYP11A1 interactions | 1.09e-07 | 9 | 23 | 3 | int:CYP11A1 | |
| Interaction | SMAD2 interactions | 1.66e-07 | 385 | 23 | 7 | int:SMAD2 | |
| Interaction | SMAD1 interactions | 2.46e-07 | 243 | 23 | 6 | int:SMAD1 | |
| Interaction | SMAD7 interactions | 2.82e-07 | 127 | 23 | 5 | int:SMAD7 | |
| Interaction | MED24 interactions | 2.93e-07 | 128 | 23 | 5 | int:MED24 | |
| Interaction | WWP1 interactions | 3.66e-07 | 260 | 23 | 6 | int:WWP1 | |
| Interaction | SMAD6 interactions | 4.55e-07 | 56 | 23 | 4 | int:SMAD6 | |
| Interaction | RUNX3 interactions | 6.44e-07 | 61 | 23 | 4 | int:RUNX3 | |
| Interaction | SKI interactions | 8.88e-07 | 160 | 23 | 5 | int:SKI | |
| Interaction | RHEBL1 interactions | 1.05e-06 | 18 | 23 | 3 | int:RHEBL1 | |
| Interaction | LEF1 interactions | 1.06e-06 | 69 | 23 | 4 | int:LEF1 | |
| Interaction | SMAD4 interactions | 1.42e-06 | 530 | 23 | 7 | int:SMAD4 | |
| Interaction | KAT2A interactions | 1.59e-06 | 180 | 23 | 5 | int:KAT2A | |
| Interaction | MBD1 interactions | 1.65e-06 | 77 | 23 | 4 | int:MBD1 | |
| Interaction | NOTCH4 interactions | 1.70e-06 | 21 | 23 | 3 | int:NOTCH4 | |
| Interaction | SMURF2 interactions | 1.82e-06 | 185 | 23 | 5 | int:SMURF2 | |
| Interaction | GJB6 interactions | 1.97e-06 | 22 | 23 | 3 | int:GJB6 | |
| Interaction | PAPPA interactions | 1.97e-06 | 22 | 23 | 3 | int:PAPPA | |
| Interaction | HOXA13 interactions | 1.97e-06 | 22 | 23 | 3 | int:HOXA13 | |
| Interaction | CXXC5 interactions | 1.97e-06 | 22 | 23 | 3 | int:CXXC5 | |
| Interaction | PSG9 interactions | 1.97e-06 | 22 | 23 | 3 | int:PSG9 | |
| Interaction | ZNF510 interactions | 2.59e-06 | 24 | 23 | 3 | int:ZNF510 | |
| Interaction | EID2 interactions | 2.59e-06 | 24 | 23 | 3 | int:EID2 | |
| Interaction | PEX6 interactions | 2.82e-06 | 88 | 23 | 4 | int:PEX6 | |
| Interaction | FOXG1 interactions | 3.83e-06 | 95 | 23 | 4 | int:FOXG1 | |
| Interaction | GLI3 interactions | 4.34e-06 | 98 | 23 | 4 | int:GLI3 | |
| Interaction | KDM6B interactions | 5.49e-06 | 104 | 23 | 4 | int:KDM6B | |
| Interaction | USP9X interactions | 6.07e-06 | 422 | 23 | 6 | int:USP9X | |
| Interaction | BACH1 interactions | 7.12e-06 | 111 | 23 | 4 | int:BACH1 | |
| Interaction | SMAD3 interactions | 8.44e-06 | 447 | 23 | 6 | int:SMAD3 | |
| Interaction | SKIL interactions | 9.38e-06 | 119 | 23 | 4 | int:SKIL | |
| Interaction | FOXO3 interactions | 1.10e-05 | 124 | 23 | 4 | int:FOXO3 | |
| Interaction | ITGB4 interactions | 1.14e-05 | 125 | 23 | 4 | int:ITGB4 | |
| Interaction | LEMD3 interactions | 1.17e-05 | 271 | 23 | 5 | int:LEMD3 | |
| Interaction | RUNX2 interactions | 1.18e-05 | 126 | 23 | 4 | int:RUNX2 | |
| Interaction | TGIF1 interactions | 1.35e-05 | 41 | 23 | 3 | int:TGIF1 | |
| Interaction | KLF10 interactions | 1.79e-05 | 45 | 23 | 3 | int:KLF10 | |
| Interaction | PARD3 interactions | 1.85e-05 | 298 | 23 | 5 | int:PARD3 | |
| Interaction | EIF4ENIF1 interactions | 1.91e-05 | 300 | 23 | 5 | int:EIF4ENIF1 | |
| Interaction | HGS interactions | 2.06e-05 | 523 | 23 | 6 | int:HGS | |
| Interaction | DVL1 interactions | 2.40e-05 | 151 | 23 | 4 | int:DVL1 | |
| Interaction | GDF6 interactions | 2.61e-05 | 7 | 23 | 2 | int:GDF6 | |
| Interaction | MXI1 interactions | 3.28e-05 | 55 | 23 | 3 | int:MXI1 | |
| Interaction | PIAS4 interactions | 4.09e-05 | 173 | 23 | 4 | int:PIAS4 | |
| Interaction | PSMD11 interactions | 4.16e-05 | 353 | 23 | 5 | int:PSMD11 | |
| Interaction | ARID1B interactions | 4.47e-05 | 177 | 23 | 4 | int:ARID1B | |
| Interaction | CHMP3 interactions | 4.93e-05 | 63 | 23 | 3 | int:CHMP3 | |
| Interaction | PAX6 interactions | 4.94e-05 | 366 | 23 | 5 | int:PAX6 | |
| Interaction | MYOD1 interactions | 6.39e-05 | 194 | 23 | 4 | int:MYOD1 | |
| Interaction | PRDM16 interactions | 6.52e-05 | 195 | 23 | 4 | int:PRDM16 | |
| Interaction | NUP214 interactions | 6.52e-05 | 195 | 23 | 4 | int:NUP214 | |
| Interaction | ZNF83 interactions | 8.17e-05 | 12 | 23 | 2 | int:ZNF83 | |
| Interaction | RGCC interactions | 8.17e-05 | 12 | 23 | 2 | int:RGCC | |
| Interaction | CDKN2B interactions | 8.99e-05 | 77 | 23 | 3 | int:CDKN2B | |
| Interaction | RELB interactions | 9.34e-05 | 78 | 23 | 3 | int:RELB | |
| Interaction | SVEP1 interactions | 9.64e-05 | 13 | 23 | 2 | int:SVEP1 | |
| Interaction | NKX3-2 interactions | 9.64e-05 | 13 | 23 | 2 | int:NKX3-2 | |
| Interaction | RAB34 interactions | 9.70e-05 | 79 | 23 | 3 | int:RAB34 | |
| Interaction | RAB2B interactions | 1.05e-04 | 81 | 23 | 3 | int:RAB2B | |
| Interaction | RFX1 interactions | 1.05e-04 | 81 | 23 | 3 | int:RFX1 | |
| Interaction | CDK8 interactions | 1.08e-04 | 222 | 23 | 4 | int:CDK8 | |
| Interaction | PKNOX1 interactions | 1.08e-04 | 82 | 23 | 3 | int:PKNOX1 | |
| Interaction | HOXD13 interactions | 1.08e-04 | 82 | 23 | 3 | int:HOXD13 | |
| Interaction | HYAL2 interactions | 1.12e-04 | 83 | 23 | 3 | int:HYAL2 | |
| Interaction | PBX1 interactions | 1.21e-04 | 85 | 23 | 3 | int:PBX1 | |
| Interaction | NEDD9 interactions | 1.21e-04 | 85 | 23 | 3 | int:NEDD9 | |
| Interaction | GSC interactions | 1.29e-04 | 87 | 23 | 3 | int:GSC | |
| Interaction | DNMT3L interactions | 1.34e-04 | 88 | 23 | 3 | int:DNMT3L | |
| Interaction | CAMK2G interactions | 1.45e-04 | 240 | 23 | 4 | int:CAMK2G | |
| Interaction | ZSCAN4 interactions | 1.48e-04 | 16 | 23 | 2 | int:ZSCAN4 | |
| Interaction | EBI3 interactions | 1.68e-04 | 17 | 23 | 2 | int:EBI3 | |
| Interaction | PIAS3 interactions | 1.68e-04 | 95 | 23 | 3 | int:PIAS3 | |
| Interaction | ACVR1B interactions | 1.68e-04 | 95 | 23 | 3 | int:ACVR1B | |
| Interaction | SQOR interactions | 1.84e-04 | 98 | 23 | 3 | int:SQOR | |
| Interaction | HIPK2 interactions | 1.84e-04 | 98 | 23 | 3 | int:HIPK2 | |
| Interaction | KAT2B interactions | 1.86e-04 | 256 | 23 | 4 | int:KAT2B | |
| Interaction | TGFBR1 interactions | 1.92e-04 | 258 | 23 | 4 | int:TGFBR1 | |
| Interaction | IRF7 interactions | 1.95e-04 | 100 | 23 | 3 | int:IRF7 | |
| Interaction | ARHGEF6 interactions | 1.95e-04 | 100 | 23 | 3 | int:ARHGEF6 | |
| Interaction | MED6 interactions | 2.01e-04 | 101 | 23 | 3 | int:MED6 | |
| Interaction | ABTB1 interactions | 2.11e-04 | 19 | 23 | 2 | int:ABTB1 | |
| Interaction | ERBIN interactions | 2.13e-04 | 265 | 23 | 4 | int:ERBIN | |
| Interaction | DACH1 interactions | 2.19e-04 | 104 | 23 | 3 | int:DACH1 | |
| Interaction | ZMYM2 interactions | 2.32e-04 | 271 | 23 | 4 | int:ZMYM2 | |
| Interaction | ZFYVE9 interactions | 2.32e-04 | 106 | 23 | 3 | int:ZFYVE9 | |
| Interaction | C1orf116 interactions | 2.34e-04 | 20 | 23 | 2 | int:C1orf116 | |
| Interaction | FOXH1 interactions | 2.52e-04 | 109 | 23 | 3 | int:FOXH1 | |
| Cytoband | 18q21.1 | 1.82e-04 | 38 | 24 | 2 | 18q21.1 | |
| Cytoband | 11p15.1 | 4.55e-04 | 60 | 24 | 2 | 11p15.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q22 | 2.17e-03 | 132 | 24 | 2 | chr15q22 | |
| Cytoband | 8p23.1 | 2.94e-03 | 154 | 24 | 2 | 8p23.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr18q21 | 5.13e-03 | 205 | 24 | 2 | chr18q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | 6.63e-03 | 234 | 24 | 2 | chr8p23 | |
| GeneFamily | SMAD family | 1.07e-17 | 8 | 18 | 6 | 750 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 2.69e-03 | 78 | 18 | 2 | 262 | |
| Coexpression | TURJANSKI_MAPK1_AND_MAPK2_TARGETS | 2.22e-10 | 12 | 23 | 4 | M15804 | |
| Coexpression | GU_PDEF_TARGETS_UP | 4.21e-07 | 71 | 23 | 4 | M3955 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_4H_BMDC_DN | 2.60e-05 | 200 | 23 | 4 | M3969 | |
| Coexpression | MATZUK_EMBRYONIC_GERM_CELL | 1.25e-04 | 19 | 23 | 2 | M1821 | |
| Coexpression | KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP | 1.47e-04 | 118 | 23 | 3 | M12313 | |
| Drug | 1,3,2-dioxaborolan-2-ol | 7.44e-10 | 104 | 23 | 6 | CID005289333 | |
| Drug | AC1L1K15 | 1.77e-09 | 120 | 23 | 6 | CID000005293 | |
| Drug | lanthanum carbide | 3.04e-09 | 19 | 23 | 4 | CID000123280 | |
| Drug | 3 tp | 5.67e-09 | 66 | 23 | 5 | CID009549240 | |
| Drug | MW 1 | 7.08e-09 | 151 | 23 | 6 | CID000073965 | |
| Drug | 5-methoxypsoralen | 3.14e-08 | 7 | 23 | 3 | ctd:C022909 | |
| Drug | Mcat | 4.06e-08 | 35 | 23 | 4 | CID003080785 | |
| Drug | LDN 193189 | 5.03e-08 | 8 | 23 | 3 | ctd:C554430 | |
| Drug | AC1L9Q5W | 6.26e-08 | 106 | 23 | 5 | CID000452221 | |
| Drug | NSC350854 | 6.88e-08 | 108 | 23 | 5 | CID000434448 | |
| Drug | LY2109761 | 1.08e-07 | 10 | 23 | 3 | ctd:C530108 | |
| Drug | galangin | 6.17e-07 | 68 | 23 | 4 | ctd:C037032 | |
| Drug | imperatorin | 1.37e-06 | 22 | 23 | 3 | ctd:C031534 | |
| Drug | AC1L9RT0 | 1.37e-06 | 22 | 23 | 3 | CID000454702 | |
| Drug | rhodioloside | 4.38e-06 | 32 | 23 | 3 | ctd:C009172 | |
| Drug | MDPC | 8.04e-06 | 39 | 23 | 3 | CID000032842 | |
| Drug | Cytochalasin D | 8.04e-06 | 39 | 23 | 3 | ctd:D015638 | |
| Drug | Madecassol | 1.33e-05 | 46 | 23 | 3 | CID000108062 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.38e-05 | 170 | 23 | 4 | 1050_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 3.04e-05 | 181 | 23 | 4 | 6951_DN | |
| Drug | sirtinol | 3.28e-05 | 62 | 23 | 3 | ctd:C439060 | |
| Drug | methotrexate polyglutamate | 3.50e-05 | 9 | 23 | 2 | ctd:C014085 | |
| Drug | protocatechualdehyde | 4.37e-05 | 10 | 23 | 2 | ctd:C005581 | |
| Drug | Felbinac [5728-52-9]; Down 200; 18.8uM; HL60; HT_HG-U133A | 4.40e-05 | 199 | 23 | 4 | 3061_DN | |
| Drug | Streptozotocin [18883-66-4]; Up 200; 15uM; HL60; HT_HG-U133A | 4.40e-05 | 199 | 23 | 4 | 2535_UP | |
| Drug | Wen-pi-tang-Hab-Wu-ling-san | 5.34e-05 | 11 | 23 | 2 | ctd:C521629 | |
| Drug | leptomycin B | 5.57e-05 | 74 | 23 | 3 | ctd:C038753 | |
| Drug | AR E | 7.73e-05 | 230 | 23 | 4 | CID004369394 | |
| Drug | Phloroglucinol | 8.82e-05 | 14 | 23 | 2 | ctd:D010696 | |
| Drug | SB203580 | 9.11e-05 | 771 | 23 | 6 | CID000176155 | |
| Drug | SIS3 | 1.02e-04 | 15 | 23 | 2 | CID010138988 | |
| Drug | aluminum chloride | 1.45e-04 | 102 | 23 | 3 | ctd:C010845 | |
| Drug | isoangustone A | 1.48e-04 | 18 | 23 | 2 | ctd:C551631 | |
| Drug | Ly-364947 | 1.48e-04 | 18 | 23 | 2 | ctd:C520284 | |
| Drug | S-nitro-N-acetylpenicillamine | 2.44e-04 | 23 | 23 | 2 | ctd:C110881 | |
| Drug | ap1-6 | 2.44e-04 | 23 | 23 | 2 | CID003030073 | |
| Drug | Simvastatin | 2.44e-04 | 581 | 23 | 5 | ctd:D019821 | |
| Drug | Grape Seed Extract | 2.66e-04 | 24 | 23 | 2 | ctd:D056604 | |
| Drug | candesartan cilexetil | 3.63e-04 | 28 | 23 | 2 | ctd:C077793 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 5.54e-04 | 161 | 23 | 3 | 4768_DN | |
| Drug | imidacloprid | 5.69e-04 | 35 | 23 | 2 | ctd:C082359 | |
| Drug | sauchinone | 5.69e-04 | 35 | 23 | 2 | ctd:C410958 | |
| Drug | acteoside | 5.69e-04 | 35 | 23 | 2 | ctd:C058956 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 5.95e-04 | 165 | 23 | 3 | 6085_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 5.95e-04 | 165 | 23 | 3 | 2835_DN | |
| Drug | pyridinyl imidazole | 6.02e-04 | 36 | 23 | 2 | CID000005171 | |
| Drug | monocrotaline pyrrole | 6.02e-04 | 36 | 23 | 2 | CID000104764 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.05e-04 | 166 | 23 | 3 | 2247_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.05e-04 | 166 | 23 | 3 | 7324_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.16e-04 | 167 | 23 | 3 | 3979_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.27e-04 | 168 | 23 | 3 | 3868_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.27e-04 | 168 | 23 | 3 | 3395_DN | |
| Drug | SPDP | 6.36e-04 | 37 | 23 | 2 | CID000100682 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.38e-04 | 169 | 23 | 3 | 6064_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 6.38e-04 | 169 | 23 | 3 | 5231_DN | |
| Drug | BW-B 70C; Up 200; 31.6uM; MCF7; HT_HG-U133A_EA | 6.38e-04 | 169 | 23 | 3 | 1132_UP | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 6.49e-04 | 170 | 23 | 3 | 7043_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.49e-04 | 170 | 23 | 3 | 5260_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 6.60e-04 | 171 | 23 | 3 | 6879_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.60e-04 | 171 | 23 | 3 | 2777_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.71e-04 | 172 | 23 | 3 | 7179_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.71e-04 | 172 | 23 | 3 | 3428_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 6.71e-04 | 172 | 23 | 3 | 1072_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.71e-04 | 172 | 23 | 3 | 2794_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 6.71e-04 | 172 | 23 | 3 | 5903_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.71e-04 | 172 | 23 | 3 | 4112_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.83e-04 | 173 | 23 | 3 | 5336_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 6.94e-04 | 174 | 23 | 3 | 7105_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 6.94e-04 | 174 | 23 | 3 | 5745_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.94e-04 | 174 | 23 | 3 | 3462_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 6.94e-04 | 174 | 23 | 3 | 1659_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 6.94e-04 | 174 | 23 | 3 | 5945_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.94e-04 | 174 | 23 | 3 | 5693_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 6.94e-04 | 174 | 23 | 3 | 5940_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 7.06e-04 | 175 | 23 | 3 | 1058_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 7.06e-04 | 175 | 23 | 3 | 1014_DN | |
| Drug | 16-hydroxycleroda-3,13(14)-dien-15,16-olide | 7.07e-04 | 39 | 23 | 2 | ctd:C072581 | |
| Drug | SAHA; Down 200; 10uM; HL60; HT_HG-U133A | 7.18e-04 | 176 | 23 | 3 | 6179_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 7.18e-04 | 176 | 23 | 3 | 5976_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.18e-04 | 176 | 23 | 3 | 1535_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.18e-04 | 176 | 23 | 3 | 3312_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 7.18e-04 | 176 | 23 | 3 | 6980_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.18e-04 | 176 | 23 | 3 | 6784_DN | |
| Drug | trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 7.30e-04 | 177 | 23 | 3 | 873_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 7.30e-04 | 177 | 23 | 3 | 7550_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.30e-04 | 177 | 23 | 3 | 3177_DN | |
| Drug | aristolochic acid I | 7.42e-04 | 178 | 23 | 3 | ctd:C000228 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 7.42e-04 | 178 | 23 | 3 | 992_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 7.54e-04 | 179 | 23 | 3 | 6910_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.54e-04 | 179 | 23 | 3 | 5484_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 7.66e-04 | 180 | 23 | 3 | 5981_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 7.66e-04 | 180 | 23 | 3 | 6886_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.66e-04 | 180 | 23 | 3 | 4821_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.78e-04 | 181 | 23 | 3 | 3643_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 7.78e-04 | 181 | 23 | 3 | 7077_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 7.91e-04 | 182 | 23 | 3 | 5802_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A | 7.91e-04 | 182 | 23 | 3 | 1951_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 8.16e-04 | 184 | 23 | 3 | 7555_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 8.16e-04 | 184 | 23 | 3 | 6939_DN | |
| Drug | U0126 | 8.36e-04 | 430 | 23 | 4 | CID000005637 | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 2.00e-10 | 13 | 23 | 4 | DOID:0050787 (implicated_via_orthology) | |
| Disease | Idiopathic pulmonary hypertension | 3.46e-08 | 9 | 23 | 3 | C0152171 | |
| Disease | 2-oxo-hept-3-ene-1,7-dioate hydratase activity | 1.50e-07 | 14 | 23 | 3 | C1150929 | |
| Disease | Idiopathic pulmonary arterial hypertension | 2.30e-07 | 16 | 23 | 3 | C3203102 | |
| Disease | Familial primary pulmonary hypertension | 2.79e-07 | 17 | 23 | 3 | C0340543 | |
| Disease | Lynch syndrome (is_implicated_in) | 8.28e-07 | 24 | 23 | 3 | DOID:3883 (is_implicated_in) | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 9.45e-06 | 53 | 23 | 3 | C4707243 | |
| Disease | polyp of colon | 1.12e-05 | 56 | 23 | 3 | MONDO_0021400 | |
| Disease | Loeys-Dietz Syndrome | 1.22e-05 | 7 | 23 | 2 | C2697932 | |
| Disease | Pulmonary arterial hypertension | 2.61e-05 | 10 | 23 | 2 | C2973725 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 3.27e-05 | 80 | 23 | 3 | DOID:6432 (biomarker_via_orthology) | |
| Disease | progesterone measurement | 5.26e-05 | 14 | 23 | 2 | EFO_0007004 | |
| Disease | Colorectal Neoplasms | 5.85e-05 | 277 | 23 | 4 | C0009404 | |
| Disease | pancreatic cancer (is_implicated_in) | 8.92e-05 | 112 | 23 | 3 | DOID:1793 (is_implicated_in) | |
| Disease | Cocaine-Related Disorders | 1.02e-04 | 117 | 23 | 3 | C0236736 | |
| Disease | Left Ventricle Remodeling | 1.21e-04 | 21 | 23 | 2 | C0600520 | |
| Disease | Ventricular Remodeling | 1.21e-04 | 21 | 23 | 2 | C0600519 | |
| Disease | Cocaine Abuse | 1.29e-04 | 127 | 23 | 3 | C0009171 | |
| Disease | Cocaine Dependence | 1.69e-04 | 139 | 23 | 3 | C0600427 | |
| Disease | Colorectal Carcinoma | 1.77e-04 | 702 | 23 | 5 | C0009402 | |
| Disease | colorectal cancer, colorectal adenoma | 2.20e-04 | 152 | 23 | 3 | EFO_0005406, MONDO_0005575 | |
| Disease | Craniofacial Abnormalities | 2.38e-04 | 156 | 23 | 3 | C0376634 | |
| Disease | endometrial cancer (is_marker_for) | 3.40e-04 | 35 | 23 | 2 | DOID:1380 (is_marker_for) | |
| Disease | colon cancer (biomarker_via_orthology) | 4.23e-04 | 39 | 23 | 2 | DOID:219 (biomarker_via_orthology) | |
| Disease | ovarian cancer (is_implicated_in) | 8.72e-04 | 56 | 23 | 2 | DOID:2394 (is_implicated_in) | |
| Disease | Withdrawal Symptoms | 9.36e-04 | 58 | 23 | 2 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 9.36e-04 | 58 | 23 | 2 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 9.36e-04 | 58 | 23 | 2 | C0038587 | |
| Disease | osteoarthritis, hip, osteoarthritis, knee | 1.07e-03 | 62 | 23 | 2 | EFO_0004616, EFO_1000786 | |
| Disease | asthma, age at onset | 1.36e-03 | 70 | 23 | 2 | EFO_0004847, MONDO_0004979 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GHQRPWWKVLPLSCF | 71 | Q4G0I0 | |
| YWVKAELHRPWLLPV | 136 | Q96B67 | |
| PWECYHLIWKILPYI | 31 | O43869 | |
| LWKNHRPWPALGRGY | 281 | O95461 | |
| RAWKWLRLPCHDFAP | 401 | Q2TV78 | |
| PWIAGLWPALRKHFR | 141 | Q9UBK8 | |
| RCYHLRHKVLPRWVW | 541 | Q6UWB1 | |
| PKGRWLWLDYVLVVP | 1366 | O15230 | |
| GKKCCRRWWILEPYP | 56 | P0DP73 | |
| RHQRKYWCRLGPPRW | 91 | Q8WWV6 | |
| RPSLYLPVWWECGKH | 1566 | Q8TD26 | |
| GKKCCRRWWILEPYP | 56 | P0DP74 | |
| KKPRIVLPWWCVYVA | 1566 | Q9NTG1 | |
| PHVIYARLWRWPDLH | 91 | Q13485 | |
| GIEPYCVKHWWVRLL | 866 | Q149N8 | |
| AWLRRYIKWPLLPPK | 606 | Q8IYB8 | |
| VLWPIWYRCRRPRHL | 131 | Q96LB1 | |
| CLSVLWPIWYRCRRP | 121 | Q96LA9 | |
| GLPHVIYCRVWRWPD | 86 | O15198 | |
| RKGLPHVIYCRVWRW | 81 | Q99717 | |
| KGLPHVIYCRVWRWP | 81 | Q15797 | |
| KGLPHVIYCRLWRWP | 121 | Q15796 | |
| KGLPHVIYCRLWRWP | 81 | P84022 | |
| KPYLPLHTNGRRWWK | 361 | Q709C8 | |
| PVYRWKPQKWSPCIL | 796 | Q9C0I4 |